Av. de Huelva, 8. 06005 Badajoz

info@areasaludbadajoz.com

info@areasaludbadajoz.com

Search

Brolucizumab for treating wet age-related macular degeneration.Technology appraisal guidance [TA672] (Febrero 2021)

brolucizumab for treating wet agerelated macular degeneration pdf 82609316228293 Página 01